Description

According to the Market Statsville Group (MSG), the global sepsis diagnostics market size is expected to grow from USD 570 million in 2021 to USD 1,111.26 million by 2030, at a CAGR of 7.7% from 2022 to 2030. Demand for sepsis diagnostic equipment is projected to increase as a result of growing public-private funding for sepsis diagnostic research activities, rising infectious illness prevalence, an increase in sepsis incidences, and growing government initiatives to increase sepsis awareness.

Global Sepsis Diagnostics Market Definition

Sepsis is a life-threatening disease that occurs when the body's immune system reacts to an infection by attacking its tissues. When the body's infection-fighting mechanisms kick in, organs perform badly and improperly. Sepsis can lead to septic shock. This abrupt drop in blood pressure can harm organs and even cause death. Antibiotics and intravenous fluids should be administered as soon as possible to increase the chances of survival.

Scope of the Global Sepsis Diagnostics Market

The study categorizes the sepsis diagnostics market based on method, product, technology, usability, pathogen, and end-user at the regional and global levels.

By Method (Sales, USD Million, 2017-2030)

• Conventional Diagnostics
• Automated Diagnostics

By Product (Sales, USD Million, 2017-2030)

• Blood Culture Media
• Instruments
• Assay kits & Reagents
• Software

By Technology (Sales, USD Million, 2017-2030)

• Microbiology
• Molecular Diagnostics
  • PCR
  • Peptide Nucleic Acid-Fluorescent In Situ Hybridization
  • Microarrays
  • DNA sequencing
  • Syndromic Panel-Based Testing
• Immunoassays
• Flow Cytometry
• Microfluidics
• Flow Cytometry

By Usability (Sales, USD Million, 2017-2030)

• Laboratory Testing
• Point-of-care Testing

By Pathogen (Sales, USD Million, 2017-2030)

• Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis
• Fungal Sepsis
• Viral Sepsis
• Others

By End-User (Sales, USD Million, 2017-2030)

• Hospitals and specialty clinics
• Pathology & Reference Laboratories
• Research Laboratories & Academic Institutes

By Region (Sales, USD Million, 2017-2030)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • Poland
  • Russia
  • The Netherlands
  • Norway
  • Czech Republic
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Malaysia
  • Thailand
  • Singapore
  • Australia & New Zealand
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Northern Africa
  • Rest of MEA

Bacterial sepsis segment is projected to account for the largest market share by pathogen

In 2021, the bacterial sepsis segment accounted for the largest market share in the global sepsis diagnostics market. This growth can be associated with an increase in bacterial sepsis cases, an increase in surgical operations, and an increase in the prevalence of HAIs. Moreover, the growing chronic diseases and fungal infections may drive the segmental growth over the forecast period.

APAC accounts for the highest CAGR during the forecast period

Globally, APAC is estimated to hold the highest CAGR in the global sepsis diagnostics market during the forecast period. This region's high population increase, as well as expanding urbanization and industrialization, are driving the market growth. The main factors for the market's growth in the region are the surging expenditure on healthcare by developing nations’ government and their support.

Key Market Players in the Global Sepsis Diagnostics Market

The global sepsis diagnostics market is highly competitive, with key industry players adopting strategies such as product development, partnerships, acquisitions, agreements, and expansion to strengthen their market positions. Most market companies focus on expanding operations across regions, augmenting their capabilities, and building strong partner relations.

Major players in the global sepsis diagnostics market are:

• BioMerieux SA
• Thermo Fisher Scientific Inc.
• Abbott Laboratories, Inc.
• Becton, Dickinson, and Company
• Bruker Corporation
• Beckman Coulter, Inc.
• T2 Biosystems, Inc
• Nanosphere, Inc.
• Hoffmann-LA Roche Ltd
• Danaher Corporation

Recent Developments

• In May 2020, Bechman Coulter made its DxH 690T hematology analyzer available in the US. The DxH 690T is a table-top version of the company’s flagship DxH 900 large-volume hematology analyzer, designed to expedite workflow and reduce downtime in mid-volume facilities.
• In October 2021, Prenosis, Inc. announced the expansion of the existing collaboration with Roche Diagnostics to improve and help accelerate the clinical detection of sepsis using enhanced diagnostics.

Key Issues Addressed

• What is the market size by various segmentation of the sepsis diagnostics by region and its respective countries?
• What are the customer buying behavior, key takeaways, and Porter's 5 forces of the sepsis diagnostics market?
• What are the key opportunities and trends for manufacturers involved in the sepsis diagnostics supply chain?
• What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
• What and how regulations, schemes, patents, and policies are impacting the growth of the market?
• What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
• The market player positioning, top winning strategies by years, company product developments, and launches will be?
• How has COVID-19 impacted the demand and sales of sepsis diagnostics in the global market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
• Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market.